Related Experiment Videos
Diminished TSH release after a course of ECT: altered monoamine function or seizure activity?
A I Scott1, J B Milner, P A Shering
1University Department of Psychiatry, Royal Edinburgh Hospital, Scotland.
Psychoneuroendocrinology
|January 1, 1989
Summary
Thyroid stimulating hormone (TSH) release in depressed patients undergoing electroconvulsive therapy (ECT) closely correlated with seizure activity. This finding suggests TSH release may not offer new insights into ECT's controversial treatment mechanisms.
Area of Science:
- Neuroendocrinology
- Psychiatry
- Clinical Neurophysiology
Background:
- Electroconvulsive therapy (ECT) is a controversial but effective treatment for severe depression.
- The neurobiological mechanisms underlying ECT's efficacy remain incompletely understood.
- Thyroid stimulating hormone (TSH) release has been investigated as a potential biomarker for treatment response.
Purpose of the Study:
- To investigate the relationship between TSH release and electroencephalogram (EEG) parameters during electroconvulsive therapy (ECT) in depressed patients.
- To explore whether TSH release provides novel insights into the mode of action of ECT.
Main Methods:
- Nine drug-free depressed patients undergoing ECT were studied.
- TSH levels were measured after the first and last ECT treatments.
- Six-channel EEG was used to record bilateral spike wave activity and total seizure length.
Main Results:
- A strong correlation was observed between altered TSH release post-ECT and changes in bilateral spike wave activity (r = 0.99, p < 0.001).
- TSH release also showed a significant correlation with total seizure length (r = 0.72, p < 0.05).
Conclusions:
- The significant correlation between TSH release and ECT-induced seizure activity suggests that TSH dynamics are closely linked to the physiological effects of the treatment.
- Investigating TSH release is unlikely to yield new insights into the fundamental mechanisms of action of electroconvulsive therapy.